Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,576
Total Claims
$260K
Drug Cost
235
Beneficiaries
$1,106
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 148 Psychologist, Clinical providers
-22%
Cost per patient vs peers
$1,106 vs $1,416 avg
+11%
Brand preference vs peers
6.2% vs 5.6% avg
Brand vs Generic
Brand: 533 claims · $169K
Generic: 8,026 claims · $90K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 34 | $26K |
| Rivaroxaban | 34 | $19K |
| Apixaban | 33 | $19K |
| Insulin Nph Hum/Reg Insulin Hm | 36 | $14K |
| Insulin Lispro | 24 | $11K |
| Sitagliptin Phos/Metformin Hcl | 12 | $9,442 |
| Ticagrelor | 22 | $9,364 |
| Dapagliflozin Propanediol | 11 | $7,403 |
| Sitagliptin Phosphate | 13 | $6,861 |
| Gabapentin | 990 | $5,689 |
| Fluticasone Propion/Salmeterol | 12 | $4,789 |
| Atorvastatin Calcium | 406 | $4,360 |
| Sucralfate | 65 | $3,505 |
| Fenofibrate | 138 | $3,426 |
| Pentoxifylline | 141 | $3,028 |
Prescribing Profile
Patient Profile
72
Avg Age
46%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data